UTMD UTAH MEDICAL PRODUCTS INC
Research report · from SEC EDGAR · close 2026-07-10
$67.96 -0.6%
$216.4M mkt cap
executive summary
UTAH MEDICAL PRODUCTS INC (UTMD) is a $216.4M company. Revenue is $37.5M (-4.4% y/y) at a 29% net margin. It is profitable. Our health score is B (78/100). No major red flags on file. It funds itself; low dilution risk.
Revenue (TTM)
$37.5M
-4.4% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 0
Cash & ST investments
$87.4M
Operating cash flow
$14.7M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-10 by stocktools.ai.